𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thyrocyte-specific expression of Cre recombinase in transgenic mice

✍ Scribed by Takashi Kusakabe; Akio Kawaguchi; Rumi Kawaguchi; Lionel Feigenbaum; Shioko Kimura


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
245 KB
Volume
39
Category
Article
ISSN
1526-954X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A transgenic mouse line that expresses Cre recombinase under control of the human thyroid peroxidase (TPO) gene promoter was established. The activity and specificity of the TPO‐driven Cre recombinase were examined by using Northern blotting and by crossing with the ROSA26 reporter transgenic mouse line. In the latter mice, Cre‐mediated recombination occurred only in the thyrocytes, and recombination commenced around embryonic day 14.5, at the time during thyroid organogenesis when TPO expression begins. This study demonstrates that the TPO__‐Cre__ transgenic mouse is a powerful tool to specifically delete loxP‐inserted (floxed) genes in thyrocytes and will be of great value in the study of thyrocyte‐specific genes during development and/or in adult thyroids. genesis 39:212–216, 2004. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Podocyte-specific expression of cre reco
✍ Marcus J. Moeller; Silja K. Sanden; Abdulsalam Soofi; Roger C. Wiggins; Lawrence 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

## Abstract Summary: We report a transgenic mouse line that expresses Cre recombinase exclusively in podocytes. Twenty‐ four transgenic founders were generated in which Cre recombinase was placed under the regulation of a 2.5‐kb fragment of the human NPHS2 promoter. Previously, this fragment was sh

Transgenic mice that express Cre recombi
✍ W.S.M. Chiu; J.F. McManus; A.J. Notini; A.I. Cassady; J.D. Zajac; R.A. Davey 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB

## Abstract To study the physiological control of osteoclasts, the bone resorbing cells, we generated transgenic mice carrying the Cre recombinase gene driven by either the tartrate‐resistant acid phosphatase (TRAP) or cathepsin K (Ctsk) promoters. TRAP‐Cre and Ctsk‐Cre transgenic mouse lines were